glp 1 and gallbladder GLP-1 receptor agonists disease risk: insights into molecular mechanisms and clinical implications GLP-1 & Gallbladder Disease: What
Description
The highest dose of orforglipron helped patients lose on average 10.5% of their weight, or 22.9 pounds, on average at 72 weeks, compared to 2.2% weight loss among those who took a placebo
Lancet 404 , 17611778 (2024)
Cost: Zepbound costs $1059.87 per month without insurance
In terms of safety, there was no evidence of diabetic ketoacidosis or severe hypoglycemia with acmopatide
2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines
